PRIX GALIEN MEDSTARTUP 2021 FOR COLLABORATION WITH A US MEDICAL INSTITUTION
November 8, 2021
Shahin Gharakhanian had the honor to accept on behalf of ACTICOR-BIOTECH – the PRIX GALIEN MEDSTARTUP 2021 – Award in the «collaboration» category recognizing joint work with the Memorial Hermann Hospital in Houston, Tx. Ceremony held at the Alexandria Life Sciences Center in New York 28 Oct. 2021. We are developing Glenzocimab, a humanized monoclonal antibody fragment, in Stroke and other thromboembolic conditions within internal medicine and infectious diseases indications.
Since 2019, working with Paris-based Acticor-Biotech, my organization – SG MD Consulting LLC – has deployed a highly expert Team, based in various US venues, for Clinical and Regulatory Operations. We have established a nation-wide network of investigative sites of excellence under the medical leadership of Dr Jim Grotta (Houston, Tx) who is taking Stroke Medicine to new heights, as exemplified by his recent publication (see New England Journal of Medicine 2021;385:971-81). We are humbled by this confidence and proud of our collaboration with outstanding colleagues at Acticor-Biotech led by Dr Gilles Avenard, CEO. Additionally, the company achieves a new milestone by an IPO on EURONEXT.